Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 102,936 shares at $42.08 ($4.3M) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $4.3M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.08 | 35,600 | $1.5M | 35.1% |
| 2 | $41.09 | 32,251 | $1.3M | 31.1% |
| 3 | $41.09 | 32,251 | $1.3M | 31.1% |
| 4 | $41.25 | 1,417 | $58K | 1.4% |
| 5 | $41.25 | 1,417 | $58K | 1.4% |
| Total | $41.44 avg | 102,936 |
| $4.3M |
| 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |